Telomir Pharmaceuticals, INC. 8-K Filing
Ticker: TELO · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1971532
Sentiment: neutral
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 15.2 · Accepted 2025-11-24 16:01:40
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-25-024818.txt ( ) — 206KB
- telo-20251124.xsd (EX-101.SCH) — 3KB
- telo-20251124_lab.xml (EX-101.LAB) — 34KB
- telo-20251124_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TELOMIR PHARMACEUTICALS, INC. Dated: November 24, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer